NCT03832309

Brief Summary

The objectives of this study are first to determine if the power of suggestion will decrease the frequency and severity of emergence reactions after procedural sedation and analgesia with ketamine in the setting of the emergency department. Second, to determine if people dream about what they were thinking about when they were induced with ketamine.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
38

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 21, 2017

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2018

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2021

Completed
Last Updated

April 6, 2022

Status Verified

April 1, 2022

Enrollment Period

3.6 years

First QC Date

August 2, 2018

Last Update Submit

April 5, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • T-Test

    Data gathered from post sedation questionnaire, specifically question 5, will be analyzed by comparing the two means of group one and group two using a student's T test,

    24 months

  • STAI-6

    To ensure two groups are similar to each other -demographic data, the pre and post opt sedation VAS scores, and the STAI-6 information.

    24 months

Study Arms (2)

Group 1

ACTIVE COMPARATOR

Packet 1: The Physician will be asked to instruct the patient as empathetically and confidently as possible, that the drug the patient will be given will make them feel no pain, cause them to forget the procedure, and allow them to dream the dream of their choice.

Behavioral: Do we speak to them in a way that convinces them to have the dreamBehavioral: Speaking to them as a regualar person

Control Arm

OTHER

Half of the participants will receive the sedation medication with the usual conversation while the physician is giving the medication to the patient. The other half of the participants will have a more positive conversation, (which is the study intervention), with the physician while being given the medication. Both group's emergence reactions, if any, will be compared to see if the positive conversation reduced the side effect.

Behavioral: Do we speak to them in a way that convinces them to have the dreamBehavioral: Speaking to them as a regualar person

Interventions

During induction, and depending on what group they are randomized to, the physician will speak to them about having a dream while on the drug

Control ArmGroup 1

During induction, if the patient is in group 1, the resident performing procedural sedation will remind the patient about what the patient wanted to dream and ask them to focus on that as the ketamine is being administered. If the patient is in group 2, the resident performing procedural sedation will give no specific instruction to the patient at this point.

Control ArmGroup 1

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be at least 18 years of age
  • Required need for procedural sedation and analgesia

You may not qualify if:

  • Age\< 18
  • Hypertension
  • Raised Intracranial pressure
  • Major psychological disorders
  • Procedures involving laryngel manipulations
  • History of Laryngeal sapsm History of adverse reactions to ketamine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRISTUS Health

Corpus Christi, Texas, 78404, United States

Location

MeSH Terms

Conditions

Agnosia

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Paul Crapo, DO

    CHRISTUS Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
During the consent for the study, the physician will do the following depending on which group the patient has been randomized to: Packet 1: The physician will be asked to instruct the patient as empathetically and confidently as possible, that the drug the patient will be given will make them feel not pain, cause them to forget the procedure, and allow them to dream the dream of their choice. The resident will specifically ask the patient what he or she wants to dream about and the resident will then write the patient's answer on the instruction sheet. Packet #2: They physician will be asked to read a written statement about how the drug they will be given will cause analgesia, amnesia, and may cause hallucinations.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study will be conducted in the emergency department at CHRISTUS Spohn Shoreline hospital is the region's primary acute care center. It houses the Chest Pain, Stroke, and Cancer Centers of CHRISTUS Spohn and is the only level II trauma center in south Texas. It is a major affiliate of Texas A\& M medical school, and serves an inner-city population
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 2, 2018

First Posted

February 6, 2019

Study Start

November 21, 2017

Primary Completion

June 21, 2021

Study Completion

June 21, 2021

Last Updated

April 6, 2022

Record last verified: 2022-04

Locations